CompletedNot applicableNCT03420235

Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Erasmus Medical Center
Principal Investigator
Marlies Wijsenbeek, MD PhD
Erasmus Medical Center
Intervention
Home monitoring program(other)
Enrollment
90 target
Eligibility
18 years · All sexes
Timeline
2018 – 2019

Study locations (1)

Collaborators

OLVG · St. Antonius Hospital · Zuyderland Medical Centre

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03420235 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials